Factors associated with the use of pap smear testing in Greece

Journal of Women's Health
Effie SimouGeorgia Kourlaba

Abstract

The purpose of this study was to describe the rate of Papanicolaou (Pap) smear test use among women participating in a breast cancer screening program in Greece and to determine related factors. Between March 2004 and July 2009, 9682 women aged between 40 and 69 years were recruited into the program. Baseline sociodemographic and lifestyle characteristics were recorded, together with familial medical history and the last time they had undergone a Pap test. Almost 7% of the participants had never had a Pap test, and 28.8% had not had one within the last 3 years. Factors that were found to be independently associated with never receiving a Pap test or with not having one within the last 3 years included age, educational status, marital status, area of residence, health insurance, nationality, oral contraceptive use, cancer family history, body mass index (BMI), and stability of menstrual cycle. The rate of Pap test use is high among women who reside in Greece, although it is possible that this rate is a little overestimated. Specific programs should be developed and implemented that aim to increase awareness of the benefits of regular cervical cancer screening among specific subgroups of women.

References

Mar 15, 1987·International Journal of Cancer. Journal International Du Cancer·K MagnusA Andersen
Aug 1, 1997·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·M ArbynH Van Oyen
Aug 17, 1999·International Journal of Cancer. Journal International Du Cancer·P NieminenM Hakama
Sep 28, 2002·American Journal of Preventive Medicine·Tung T NguyenJeremiah Mock
Nov 28, 2002·Preventive Medicine·Mohammad Siahpush, Gopal K Singh
Oct 24, 2003·Preventive Medicine·Usha Sambamoorthi, Donna D McAlpine
Aug 18, 2004·Preventive Medicine·Mohsen BazarganRichard S Baker
Jul 14, 2005·British Journal of Cancer·G RoncoUNKNOWN Turin Cervical Screening Working Group
Jun 23, 2006·Journal of Immigrant and Minority Health·Nadia IslamNavneet Kathuria
Mar 21, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ArbynJ Ferlay
Oct 5, 2007·Cancer Control : Journal of the Moffitt Cancer Center·Patricia BesslerPauline Jolly
Mar 29, 2008·Journal of Lower Genital Tract Disease·Luis M Puig-TintoréF Xavier Bosch
Apr 9, 2008·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Gilles GrangéAbdelkader El Hasnaoui
Dec 2, 2008·Cytopathology : Official Journal of the British Society for Clinical Cytology·J JordanW Prendiville
Mar 17, 2009·Revista de saúde pública·Luís Felipe Leite MartinsLuiz Claudio Santos Thuler
Jul 25, 2009·Ethnicity & Health·Victoria M TaylorJ Carey Jackson
Aug 22, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Marc ArbynAhti Anttila
Feb 24, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ArbynL von Karsa

❮ Previous
Next ❯

Citations

Jan 30, 2014·Journal of Geriatric Oncology·Sanghoon LeeKyu Wan Lee
Sep 24, 2015·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Melissa A Davey-RothwellCarl A Latkin
Jan 24, 2014·Health & Social Care in the Community·Maria M MoudatsouAnastasios E Philalithis

❮ Previous
Next ❯

Methods Mentioned

BETA
hysterectomy

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.